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A series containing ten (E)-2-(1-phenylethylidene)-1-tosylhydrazines have been synthesized by thionyl chloride catalyst 
assisted condensation between 1-tosylhydrazine and substituted acetophenones. These benzylidenes have been characterized 
by their physical constants, UV-Vis, IR, 1H and 13C NMR spectral techniques. The antibacterial and antifungal activities of 
the synthesized benzylidene have been evaluated. 
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Nitrogen-containing compounds have been known to 
have a tremendous potential in various fields of 
organic chemistry. The nitrogen containing organic 
compounds, providing great biological properties, the 
nitrogen atoms can act as donors and find applications 
in the construction of supramolecular blocks. 
Hydrazine derivatives constitute a versatile class of 
compounds in organic chemistry. The compounds 
containing hydrazone group possess a wide range of 
biological activities1-6. Organic chemistry is probably 
the most active and important field of heterocyclic 
chemistry at the moment, due to its extreme 
applicability to both biochemistry and petro chemistry 
where the prime concern is the synthesis of new 
organic molecules7-9. 
The chemical properties of hydrazines have been 
widely investigated because of their chelating 
capability and their pharmacological applications10 in 
several research fields. The heterocyclic hydrazines 
constitute an important class of biologically active 
drug molecules that have become an attracted 
attention of medicinal chemists due to their anti-
tubercular activity. The presence of –HN-N=CH- 
group is responsible for their biological activities  
and they are more significantly considered in the 
development of novel drugs11-19. Hydrazine 
compounds containing and they have wide range of 
biological activities like anti-microbial20-22, anti-
mycobacterial23,24, anti-convulsant25, anti-analgesic26, 
anti-inflammatory27, anti-platelet28, anti-tumoral  
 
activities29, antiviral30, antimalarial31, anticancer32,33, 
anti-tubercular34,35, anticonvulsant36, antiplatelet36, 
antiviral37, antioxidant38-40, anticancer41, neuro-
protective42, herbicidal43 and antiproliferative44 
activities. In addition, hydrazones have been  
reported to possess anti-cancer45-47 and anti-HIV 
properties48-55. The heterocyclic compounds 
containing hydrazone functionality playing an 
important role in deciding the extent of their 
pharmacological properties56. In this research work 
explain with the reaction of 1-tosylhydrazine with 
different substituted acetophenones to form 
substituted (E)-2-(1-phenylethylidene)-1-tosylhydrazines 
and the structure of all the various synthesized 
hydrazine were confirmed by elemental analysis,  
UV, FT-IR, 1H and 13C NMR Spectral data.  
The above spectral data are used to confirm  
these substituted(E)-2-(1-phenylethylidene)-1-
tosylhydrazines compounds. 
 
Results and Discussion 
 
Anti-microbial Activities 
All the aryl hydrazides possess a wide range of 
biological activities these multi-prolonged activities 
are associated with different substituents and the 
unsaturation of C=N moiety in between the aryl rings. 
Hence, it is intended to examine their antimicrobial 
activities against their respective microbes-bacterial 
and fungal strains. 
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Antibacterial Sensitivity Assay 
Antibacterial sensitivity assay has been performed 
by using disc diffusion technique57. In each Petri 
plate about 0.5 mL of the test bacterial sample has 
been spread uniformly over the solidified Mueller 
Hinton agar using sterile glass spreader. Then the 
discs with 5mm diameter made up of Whatmann  
No. 1 filter paper, impregnated with the solution of 
the compound have been placed on the medium 
using sterile forceps. The plates have been incubated 
for 24 hours at 37°C by keeping the plates upside 
down to prevent the collection of water droplets  
over the medium. After 24 hours, the plates have 
been visually examined and the diameter values of 
the zone of inhibition were measured. Triplicate 
results have been recorded by repeating the same 
procedure. 
The antibacterial screening effect of synthesized 
(E)-2-(1-phenylethylidene)-1-tosylhydrazine compounds 
have been studied against fourgram positive 
pathogenic strains S. aureus, S. pyogenes, M. luteus, 
B. substilis and six gram negative strains  
K. pneumoniae, V. cholerae, K. oxytoca, P. mirabilis, 
E. coli, P. aeruginosa shown in Figure 1 contains 
Plates (1-20) and the zone of inhibition values are 
given in Table I. The zone of inhibition is compared 
using Table I is the corresponding clustered column 
chart is shown in Figure 2. A good antibacterial 
activity has been possessed by all substituents on the 
microorganisms in general. All hydrazones showed  
 
 
 
Figure 1 — Antibacterial activities of substituted (E)-2-(1-phenylethylidene)-1-tosylhydrazine compounds
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satisfactory and moderate antifungal activity against 
S. aureus. Halogens, 4-OH, 4-CH3, 3-NO2 substituted 
hydrazones showed good antibacterial activity against 
S. Pyogenes. Parent, 2-OH and 3-OH substituted 
hydrazones showed satisfactory antifungal activity. 
The 4-NO2 substituted hydrazones have no antifungal 
activity against S. Pyogenesstain. Hydrazones 
containing3-OH, 4-OH, 4-CH3 and 3-NO2 substituents 
have good antibacterial activity against M. Luteus 
bacterial strains. The parent, Halogens, 2-OH and  
4-NO2 have satisfactory antibacterial activity against 
M. Luteus bacterial strains. Compounds containing  
4-Br, 4-I and 4-CH3 substituents have good 
antibacterial activity against B. Substilisbacterial 
strain. Parent, 4-F, 3-OH, 4-OH and nitro substituted 
hydrazones shows satisfactory antibacterial activity. 
The 2-OH substituted hydrazone have no antibacterial 
activity against B. Substilisbacterial strain. All 
substituted hydrazones except 4-I and 2-OH 
substituents shows good antibacterial activity against 
K. Pneumoniae antibacterial microbe. Hydrzone 
derivatives having 2-OH and 4-CH3 showed good 
antibacterial activity against V. Cholerae bacterial 
stain. Parent compound have no antibacterial activity. 
The remaining substituted hydrazones shows 
satisfactory antibacterial activity against V. cholerae 
 
Table I — Antibacterialactivity of substituted(E)-2-(1-phenylethylidene)-1-tosylhydrazines 
Entry X Zone of inhibition(mm) values 
Gram +ve Bacteria Gram −ve Bacteria 
S.  
aureus 
S.  
pyogenes 
M.  
luteus 
B.  
substilis 
K.  
Pneumoniae 
V.  
Cholerae 
K.  
Oxytoca 
P.  
Mirabilis 
E. 
Coli 
P. 
Aeruginosa
1 H 7 6 6 6 7 0 6 6 6 6 
2 4-Br 7 7 6 7 6 6 7 7 6 0 
3 4-F 6 7 6 6 6 6 6 6 0 6 
4 4-I 6 7 6 7 0 6 6 6 7 6 
5 2-OH 7 6 6 0 0 7 6 0 6 8 
6 3-OH 8 6 8 6 6 6 6 6 7 7 
7 4-OH 6 7 9 6 6 6 6 6 0 6 
8 4-CH3 6 7 7 7 6 7 6 8 6 7 
9 3-NO2 6 7 7 6 6 6 7 0 8 8 
10 4-NO2 6 0 6 6 6 6 7 0 8 6 
Standard Ciprofloxacin 14 11 12 12 10 12 10 12 12 10 
Control DMSO 0 0 0 0 0 0 0 0 0 0 
 
 
 
Figure 2 — Antibacterial activities of substituted(E)-2-(1-phenylethylidene)-1-tosylhydrazine compounds-clustered column chart 
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bacterial stain. All hydrazone derivatives shows good 
antibacterial activity against K. oxytoca antimicrobial 
stain. The 4-Br and 4-CH3 substituted hydrazones 
showed good antibacterial activity against P. mirabilis 
antimicrobe. Hydrazones containing2-OH and 4-NO2 
substituents have no antibacterial activity against  
P. mirabilis stain. Remaining substituted hydrazones 
shows satisfactory antibacterial activity. The 
substituents 4-I, 3-OH and nitro containing 
hydrazones shows good antibacterial activity against 
E. coli stain. Hydrazone having the substituents H,  
4-Br, 2-OH and 4-CH3 showed satisfactory 
antibacterial activity against E. coli antimicrobial 
stain. The substituents 4-F and 4-OH have no 
antibacterial activity against E. coli antimicrobe. 
showed all substituted hydrazones showed good 
antibacterial activity against P. aeruginosa stain 
except 4-Br substituent.  
 
Antifungal Sensitivity Assay 
Antifungal sensitivity assay has been performed 
using disc diffusion technique. PDA medium was 
prepared and sterilized as above. It has been poured 
(ear bearing heating condition) in the Petri-plate 
which has been already filled with 1 mL of the fungal 
species. The fungal activities of the synthesized(E)-2-
(1-phenylethylidene)-1-tosylhydrazinecompounds 
have been studied against three fungal species  
A. niger, M. specie, and T. viride.  
The plates have been rotated clockwise and counter 
clock-wise for uniform spreading of the species. The 
discs have been impregnated with the test solution. 
The test solution has been prepared by dissolving 15 
mg of the imines in 1 mL of DMSO solvent. The 
medium have been allowed to solidify and kept for 24 
hours. Then the plates have been visually examined 
and the diameter values of zone of inhibition have 
been measured. Triplicate results have been recorded 
by repeating the same procedure. The antifungal 
activities of substituted (E)-2-(1-phenylethylidene)-1-
tosylhydrazine have been studied and are shown in 
Figure 3 for Plates (21-26) and the zone of inhibition 
values of the effect is given in Table II. The clustered 
column chart, shown in Figure 4. It reveals that the 
compounds with H, 4-Br, 4-F 4-I and 2-
OHsubstituents have bestantifungal activity against all 
fungal species namely A. nigerantifungal stain. The 3-
OH, 4-OH and 4-NO2substituted hydrazones have 
good antifungal activity. Compounds containing 4-
CH3 and 3-NO2substituents have no antifungal 
activity. The hydrazone having 4-Br, 4-F 4-I and3-
NO2substituentsshows good antifungal activity 
against M. species antifungal microbe. The 
substituents H, 2-OH, 3-OH, 4-OH, 4-CH3 and 4-NO2 
substituents have not shown antifungal activity 
against M. species stain. Hydrazone derivatives 
having the substituents 4-Br, 4-F, 4-I, 2-OH, 4-OH,  
4-NO2 shows good antifungal activity against T. viride 
antifungal stain. The substituents with H (Parent),  
4-CH3 and 4-NO2 substituents have not shown 
antifungal activity against T. viride antifungal stain. 
 
Experimental Section 
All chemicals were procured from Aldrich 
Chemical Company, Bangalore. The melting points of 
all prepared tosylhydrazines were recorded in Suntex  
 
 
Figure 3 — Antifungal activities of substituted (E)-2-(1-
phenylethylidene)-1-tosylhydrazine compounds 
 
Table II — Antifungal activities of substituted (E)-2- 
(1-phenylethylidene)-1-tosylhydrazines Zone of  
inhibition(mm) values 
Entry X A. niger M. speci T. viride
1 H 8 0 0 
2 4-Br 8 6 6 
3 4-F 8 6 6 
4 4-I 8 6 6 
5 2-OH 8 0 6 
6 3-OH 6 0 0 
7 4-OH 6 0 6 
8 4-CH3 0 0 0 
9 3-NO2 0 6 0 
10 4-NO2 6 0 6 
Standard  Miconazole 6 7 6 
Control DMSO 0 0 0 
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melting point apparatus and are uncorrected. The  
UV-Vis spectra of the tosylhydrazines synthesized 
have been recorded using double beam-ELICO BL222 
Bio-Spectrophotometer. Fourier transform infrared 
spectra (KBr, 4000-400 cm−1) have been documented 
on AVATAR-300 FT-IR spectrophotometer. The 
Bruker-500 MHz NMR spectrometers were used  
for 1H and 13C NMR spectra in CDCl3 solvent  
using tetramethylsilane as internal standard. Micro 
analyses of all compounds were performed in 
Thermo-Fennigan CHN analyzer. 
 
General procedure for preparation 
The thionyl chloride catalyst was used for synthesis 
of hydrazines by condensation of 1-tosylhydrazine 
and substituted acetophenones. Equimolar quantities 
of 1-tosylhydrazine (100 mmol) and meta and para 
substituted acetophenones (100 mmol) and 15 mL of 
diethyl ether and (0.01mol) of thionyl chloride were 
placed in a Borosil round bottomed flask and mixed 
thoroughly58. The reaction mixture was vigorously 
stirred at room temperature for 30 minutes 
(Scheme I). After completion of the reaction mixture, 
1-tosylhydrazine and aromatic ketones as monitored 
by thin layer chromatography, the mixture could stand 
for 20 minutes without disturbance. The unreacted 
reagents were removed by filtration method. The 
filtrate was washed with distilled water and 
recrystallized by absolute ethanol, dried and kept in a 
desiccator. 
The synthesized substituted (E)-2-(1-
phenylethylidene)-1-tosylhydrazines has been 
analysed by their micro analysis and spectroscopic 
data and are presented in Table III and Table IV. 
 
 
Figure 4 — Antifungal activities ofsubstituted (E)-2-(1-phenylethylidene)-1-tosylhydrazine compounds-clustered column chart 
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Scheme I — Synthesis of substituted 2-benzylidene-1-tosylhydrazines 
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Conclusions 
A series of ten numbers of substituted (E)-2-(1-
phenylethylidene)-1-tosylhydrazine compoundshave 
been synthesized by condensation of 1-tosylhydrazine 
and substituted acetophenones. These synthesized 
substituted (E)-2-(1-phenylethylidene)-1-tosylhydrazine 
compounds have been characterized by their physical 
constants, spectral data. The UV, IR, NMR spectral 
data of these aryl hydrazides has been correlated with 
Hammett substituent constants and F and R 
parameters. From the results of statistical analyses the 
effects of substituent on the spectral data have been 
studied. From the UV, IR, 1H and 13C NMR spectral 
correlations study, all are gave poor correlations with 
all Hammett substituents constants and Swain-
Lupton’s parameters. But, the multi-regression 
analyses have shown satisfactory correlations. The 
antimicrobial activities of all synthesized imines have 
been studied using Bauer-Kirby method. For good 
antibacterial and antifungal activity was possessed by 
all substituents on the microorganisms in general. 
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Table III — Physical constants of substituted (E)-2-(1-phenylethylidene)-1-tosylhydrazines 
Entry X MF MW Yield (%) m.p. (°C) Micro analysis 
Found (Calcd) (%) 
C H N 
1 H C15H16N2O2S 288 91 141-142 62.46 5.56 9.64 
(62.48) (5.59) (9.71) 
2 4-Br C15H15N2O2SBr 366 90 99-100 48.99 4.08 7.58 
(49.06) (4.12) (7.63) 
3 4-F C15H15N2O2SF 306 92 61-62 58.87 4.86 9.07 
(58.81) (4.94) (9.14) 
4 2-OH C15H16N2O3S 304 89 112-113 59.12 5.38 9.12 
(59.19) (5.46) (9.20) 
5 4-OH C15H16N2O3S 304 90 132-133 59.21 5.36 9.12 
(59.19) (5.46) (9.20) 
6 4-OH C15H16N2O3S 304 93 147-148 59.22 5.38 9.18 
(59.19) (5.46) (9.20) 
7 4-I C15H15N2O2SI 413 88 129-130 43.52 3.62 6.69 
(43.49) (3.65) (6.76) 
8 4-CH3 C16H18N2O2S 302 91 118-119 63.53 5.96 9.18 
(63.55) (6.00) (9.26) 
9 3-NO2 C15H15N3O4S 333 88 137-138 53.98 4.49 12.58 
(54.04) (4.54) (12.60) 
10 4-NO2 C15H15N3O4S 333 89 125-126 54.96 4.46 12.57 
(54.04) (4.54) (12.60) 
 
Table IV — The ultraviolet absorption maxima (λmax, nm), infrared absorptions (ʋ, cm−1) and NMR chemical shifts (δ, ppm) spectral data 
of substituted (E)-2-(1-phenylethylidene)-1-tosylhydrazinecompounds 
Entry X UV (nm) IR ʋ (cm−1) SO2 (Asymm) N-H 1H NMR(δ, ppm) 13C NMR (δ, ppm) 
λmax C=N SO2 (Asymm) N-H CH3 C-CH3 C=N CH3 C-CH3 
1 H 263.23 1568.13 1166.93 1161.74 3271.27 7.267 2.435 1.255 149.61 21.67 13.36 
2 4-Br 295. 5 1519.91 1186.22 1371.39 3188.33 7.268 2.413 1.256 163.51 21.64 16.95 
3 4-F 263.5 1519.91 1186.22 1373.32 3201.83 2.431 7.268 1.254 149.24 21.67 13.25 
4 2-OH 278.5 1519.91 1184.29 1303.88 3203.76 7.267 2.433 1.205 149.38 21.67 13.30 
5 3-OH 296. 5 1515. 16 1184. 29 1342. 46 3207. 62 7. 194 2. 147 1. 346 149. 61 30. 98 13. 26 
6 4-OH 284. 6 1514. 12 1186. 22 1342. 46 3205. 69 7. 194 2. 353 1. 577 144. 72 21. 65 14. 10 
7 4-I 276. 5 1519. 91 1184. 29 1373. 32 3203. 76 7. 257 2. 462 1. 234 160. 57 21. 46 15. 45 
8 4-CH3 280. 8 1515. 28 1184. 29 1342. 46 3207. 62 7. 246 2. 314 1. 264 155. 80 21. 76 16. 40 
9 3-NO2 276. 6 1514. 12 1186. 22 1342. 46 3205. 69 7. 263 2. 410 1. 276 160. 86 21. 62 13. 35 
10 4-NO2 296. 2 1510. 86 1184. 29 1342. 46 3207. 62 7. 261 2. 413 2. 135 151. 44 21. 65 13. 34 
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